Open Innovation in Drug Discovery

被引：1

作者：

Ecker, Gerhard F. ^{[1
]}

Williams-Jones, Bryn ^{[1
]}

机构：

[1] Univ Vienna, A-1010 Vienna, Austria

来源：

MOLECULAR INFORMATICS | 2012年 / 31卷 / 08期

关键词：

D O I：

10.1002/minf.201280004

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：519 / 520

页数：2

共 50 条

[1] An Open Innovation Ecosystem for Drug Discovery
Barnes, Michael R.
[J]. MEDCHEMCOMM, 2012, 3 (01) : MCW92 - MCW97
[2] Trend on open innovation for drug discovery research
Sasaki, Yayoi
[J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S12 - S12
[3] Open innovation network for drug development and drug discovery in academia
Ichijo, Hidenori
[J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S48 - S48
[4] The promise of open innovation in drug discovery: an industry perspective
Rees, Steve
[J]. FUTURE MEDICINAL CHEMISTRY, 2015, 7 (14) : 1835 - 1838
[5] Open innovation in early drug discovery: roadmaps and roadblocks
Reichman, Melvin
Simpson, Peter B.
[J]. DRUG DISCOVERY TODAY, 2016, 21 (05) : 779 - 788
[6] Open Innovation in Drug Discovery research comes of age
Judd, Duncan B.
[J]. DRUG DISCOVERY TODAY, 2013, 18 (7-8) : 315 - 317
[7] Open innovation drug discovery: A study in JQ1.
Shaw, Daniel L.
Lin, Charles Y.
Oakley, Richard P.
Semenkovich, Nicholas P.
Qi, Jun
Bradner, James E.
[J]. CANCER RESEARCH, 2013, 73 (08)
[8] Open innovation drug discovery: Structure blinded virtual screening
Franklin, Natalie
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[9] PharmaTrek: A Semantic Web Explorer for Open Innovation in Multitarget Drug Discovery
Carrascosa, Maria C.
Massaguer, Oriol L.
Mestres, Jordi
[J]. MOLECULAR INFORMATICS, 2012, 31 (08) : 537 - 541
[10] Open innovation and drug discovery startups in Japan: The importance of communication in licensing
Tomita, Kenji
[J]. ASIA PACIFIC MANAGEMENT REVIEW, 2022, 27 (04) : 282 - 291

← 1 2 3 4 5 →